Stock News

Biogen Announces Enrollment Completion of Global Phase 3 Gene Therapy Study for an Inherited Retinal Disorder
Charity to pay $4 million to resolve U.S. pharma kickback probe
Biogen shares rise on patent resolution with Sawai
Top & Flop ETFs Halfway Through Q4
Market Morning: Alibaba Goes Hong Kong, Uber Dump, Alzheimer’s Hope, Cannabis Collapse
Biogen shares fall 3%
Biogen Sheds $3 Billion in Value on Top Drug’s Patent Review

As seen on...